Correlation Between Blueprint Medicines and Relay Therapeutics
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Relay Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Relay Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Relay Therapeutics, you can compare the effects of market volatilities on Blueprint Medicines and Relay Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Relay Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Relay Therapeutics.
Diversification Opportunities for Blueprint Medicines and Relay Therapeutics
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Blueprint and Relay is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Relay Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relay Therapeutics and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Relay Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relay Therapeutics has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Relay Therapeutics go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Relay Therapeutics
Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 0.8 times more return on investment than Relay Therapeutics. However, Blueprint Medicines Corp is 1.25 times less risky than Relay Therapeutics. It trades about 0.24 of its potential returns per unit of risk. Relay Therapeutics is currently generating about 0.05 per unit of risk. If you would invest 9,033 in Blueprint Medicines Corp on October 23, 2024 and sell it today you would earn a total of 1,972 from holding Blueprint Medicines Corp or generate 21.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Relay Therapeutics
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Relay Therapeutics |
Blueprint Medicines and Relay Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Relay Therapeutics
The main advantage of trading using opposite Blueprint Medicines and Relay Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Relay Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relay Therapeutics will offset losses from the drop in Relay Therapeutics' long position.| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
| Relay Therapeutics vs. Stoke Therapeutics | Relay Therapeutics vs. Pliant Therapeutics | Relay Therapeutics vs. Black Diamond Therapeutics | Relay Therapeutics vs. Arvinas |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world |